Emergent BioSolutions Inc. (EBS)
EBSNYSEBiotechnology: Pharmaceutical Preparations
$6.05
-0.0500 (-0.82%) today
At the close, Nov 10, 4:00 PM ET. After hours $6.05 +0.17%
- Market cap
- $310.55m
- P/E
- –
- EPS, last 4 quarters
- $-0.0400
- Dividend yield
- –
- Day range
- $5.82 to $6.12
- 52-week range
- $4.36 to $14.06
- Average volume
- 831.2k
- Previous close
- $6.10
Analysts
2 coveringHold1 buy, 0 hold, 1 sell
Targets a year out average $10.00, +65.3% from here
Earnings
next estimate $-0.1900Next report
Dec 2025
–
Mar 2026
+184.0%
Jun 2026
–
Sep 2026
+6.7%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $148.70m | $156.10m | $234.30m | $110.00m |
| Gross profit | $63.80m | $84.10m | $137.20m | $29.20m |
| Operating income | -$27.90m | $10.50m | -$125.10m | -$37.30m |
| Net income | -$54.60m | $6.80m | -$180.20m | -$32.70m |
Last four quarters: revenue $649.10m, margin -40.2%, free cash flow $188.40m
News
8 latest- Emergent BioSolutions Inc. Receives $22.3 million Delivery Order Modification to Supply BioThraxFintel · 6 days ago
- Emergent BioSolutions: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · Nov 3, 2026
- Emergent BioSolutions (EBS) Q3 2026 Earnings Call TranscriptThe Motley Fool · Nov 3, 2026
- Emergent Biosolutions Q3 Earnings Call HighlightsMarketBeat · Nov 2, 2026
- Swedish Orphan Biovitrum (BIOVF) Tops Q3 Earnings and Revenue EstimatesZacks · Oct 27, 2026
- Emergent Biosolutions (EBS) Soars 14.4%: Is Further Upside Left in the Stock?Zacks · Oct 6, 2026
- Emergent BioSolutions Secures $24M Contract Modification For CYFENDUS Anthrax Vaccine RTTNews · Sep 1, 2026
- Emergent BioSolutions (EBS) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 12, 2026
The company
At Emergent, our mission is to protect and save lives. For over 25 years, we've been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today's health challenges and tomorrow's threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- North America
- Website
- emergentbiosolutions.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.